NASDAQ:ENDP Endo International (ENDP) Stock Price, News & Analysis → “The Biggest Bubble of All Time” – Here’s What to Do. (From Chaikin Analytics) (Ad) Free ENDP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.0006▼$0.000750-Day Range$0.28▼$0.7552-Week Range$0.28▼$7.07Volume6,756 shsAverage Volume28.19 million shsMarket Capitalization$141,085.80P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaSustainabilityStock AnalysisCompetitorsHeadlinesSocial MediaSustainability Get Endo International alerts: Email Address Ad Chaikin Analytics“The Biggest Bubble of All Time” – Here’s What to Do.Despite AI's incredible run-up in 2023, we're getting some conflicting messages. Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse. Even AI leaders (the people who benefit the most!) are getting worried.Just click here. About Endo International Stock (NASDAQ:ENDP)Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.Read More Ad Chaikin Analytics“The Biggest Bubble of All Time” – Here’s What to Do.Despite AI's incredible run-up in 2023, we're getting some conflicting messages. Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse. Even AI leaders (the people who benefit the most!) are getting worried.Just click here. ENDP Stock News HeadlinesApril 22, 2024 | markets.businessinsider.comEndo International's Par Pharmaceutical Expands Recall Of Treprostinil InjectionApril 13, 2024 | financialpost.comC.K. McWhorter Endows Maison Goyard With Esteemed McWhorter Family Trust Warrant Of ExcellenceApril 25, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)April 13, 2024 | financialpost.comC.K. McWhorter Endows Wimbledon Championships With Esteemed McWhorter Family Trust Warrant Of ExcellenceApril 13, 2024 | bloomberg.comEndo Sells $2.5 Billion of Debt to Fund Its Exit From BankruptcyApril 10, 2024 | benzinga.comAmphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused CompaniesApril 2, 2024 | financialpost.comC.K. McWhorter Endows Gulfstream Aerospace with Prestigious McWhorter Family Trust Warrant for Excellence in Sustainable Luxury AviationMarch 30, 2024 | financialpost.comC.K. McWhorter Endows Tems’ ‘Me & U’ Music Video with Esteemed McWhorter Family Trust Global Digital Archive Family Trust Warrant Of ExcellenceApril 25, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)March 29, 2024 | msn.comSelf-compassion could help endometriosis sufferersMarch 26, 2024 | bitcoinist.comScoring A Win: Mastercard Endorses Ripple For Global Remittances – A Boost For XRP?March 19, 2024 | wsj.comGeorge Lucas Endorses Disney and CEO Bob Iger in Proxy FightMarch 19, 2024 | reuters.comDrugmaker Endo receives US court approval for bankruptcy restructuringMarch 16, 2024 | finance.yahoo.comEndo International plc (ENDP)March 15, 2024 | bitcoinist.comXRP Scores Regulatory Win: European Governance Institute Endorses Non-Security StatusMarch 13, 2024 | financialpost.comAmerican Perceptions Shift from Skepticism to Endorsement with Direct AI Engagement, according to Insurity’s 2024 AI in Insurance ReportMarch 12, 2024 | bitcoinist.comRap Star Drake Brings Bitcoin To The Masses With Saylor VideoMarch 9, 2024 | benzinga.comFormer House Speaker Nancy Pelosi Labels Mitch McConnell's Trump Endorsement As 'Sad, Professional Tragedy'March 8, 2024 | wsj.comEndo’s Chapter 11 Plan Has Unusual Provision Leaving Door Open to LitigationMarch 7, 2024 | rttnews.comNikki Haley Quits GOP Presidential Race Without Endorsing Trump March 2, 2024 | financialpost.comHaley Gets First Senate GOP Endorsements From Murkowski, CollinsFebruary 29, 2024 | msn.comPa. drugmaker Endo agreed to pay up to $465 million to settle criminal and civil claims related to opioid marketingFebruary 29, 2024 | reuters.comDrugmaker Endo reaches $465 mln bankruptcy settlement with US governmentFebruary 25, 2024 | benzinga.comEndo International Stock (OTC:ENDPQ) Dividends: History, Yield and DatesFebruary 21, 2024 | financialpost.comSeizing Frozen Russian Assets Over Ukraine War Wins Endorsement of Legal ExpertsFebruary 14, 2024 | wsj.comThe Small University Endowment That Is Beating the Ivy LeaguesFebruary 13, 2024 | benzinga.comDonald Trump Wants Taylor Swift's Endorsement And Says He 'Likes Her Boyfriend' Travis Kelce —- 'Even Though He's A Liberal And Probably Can't Stand Me'See More Headlines Receive ENDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Endo International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ENDP CUSIP29264F20 CIK1593034 Webwww.endo.com Phone(531) 268-2000Fax800-329-3636Employees3,103Year Founded1997Profitability EPS (Most Recent Fiscal Year)($11.07) Trailing P/E RatioN/A Forward P/E Ratio0.00 P/E GrowthN/ANet Income$-613,240,000.00 Net Margins-93.31% Pretax Margin-91.14% Return on Equity-34.25% Return on Assets6.72% Debt Debt-to-Equity RatioN/A Current Ratio1.86 Quick Ratio1.62 Sales & Book Value Annual Sales$2.99 billion Price / Sales0.00 Cash Flow$0.01 per share Price / Cash Flow0.06 Book Value($13.60) per share Price / Book0.00Miscellaneous Outstanding Shares235,143,000Free Float232,321,000Market Cap$141,085.80 OptionableNo Data Beta1.15 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Blaise A. Coleman (Age 48)Pres, CEO & Director Comp: $20.93MMr. Mark T. Bradley (Age 52)Exec. VP & CFO Comp: $6.27MMr. Matthew Joseph Maletta (Age 50)Exec. VP, Chief Legal Officer & Company Sec. Comp: $7.02MMr. Patrick A. Barry (Age 54)Exec. VP & Pres of Global Commercial Operations Comp: $6.15MFrank B. RacitiVP, Controller & Chief Accounting OfficerMs. Cheryl StouchSr. VP of Information Technology & Chief Information OfficerMs. Laure E. ParkSr. VP of Investor Relations & Corp. AffairsMs. Susan WilliamsonSr. VP & Chief Compliance OfficerMs. Tracy BassoChief HR OfficerMr. James PappHead of Endo Ventures Limited & Sr. VP of Global Supply ChainMore ExecutivesKey CompetitorsCalithera BiosciencesNASDAQ:CALAScopus BioPharmaNASDAQ:SCPSAthersysNASDAQ:ATHXAptevo TherapeuticsNASDAQ:APVOAmpio PharmaceuticalsNYSE:AMPEView All Competitors ENDP Stock Analysis - Frequently Asked Questions How were Endo International's earnings last quarter? Endo International plc (NASDAQ:ENDP) posted its quarterly earnings data on Thursday, November, 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.34. The firm earned $772.03 million during the quarter, compared to analysts' expectations of $667.94 million. Endo International had a negative trailing twelve-month return on equity of 34.25% and a negative net margin of 93.31%. The company's revenue for the quarter was up 21.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.52 EPS. What is Paul Campanelli's approval rating as Endo International's CEO? 25 employees have rated Endo International Chief Executive Officer Paul Campanelli on Glassdoor.com. Paul Campanelli has an approval rating of 86% among the company's employees. What other stocks do shareholders of Endo International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Endo International investors own include Teva Pharmaceutical Industries (TEVA), Bausch Health Companies (BHC), Mallinckrodt (MNK), Gilead Sciences (GILD), TherapeuticsMD (TXMD), Micron Technology (MU), Cleveland-Cliffs (CLF), Pfizer (PFE), Advanced Micro Devices (AMD) and NVIDIA (NVDA). This page (NASDAQ:ENDP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmith“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endo International plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.